ARS Investment Partners’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-51,181
| Closed | -$157K | – | 116 |
|
|
2019
Q3 | $157K | Hold |
51,181
| – | – | 0.03% | 105 |
|
|
2019
Q2 | $102K | Buy |
51,181
+26
| +0.1% | +$52 | 0.02% | 133 |
|
|
2019
Q1 | $220K | Sell |
51,155
-113,129
| -69% | -$487K | 0.04% | 108 |
|
|
2018
Q4 | $522K | Sell |
164,284
-163,468
| -50% | -$519K | 0.11% | 92 |
|
|
2018
Q3 | $1.72M | Buy |
327,752
+2,375
| +0.7% | +$12.5K | 0.27% | 68 |
|
|
2018
Q2 | $1.74M | Buy |
325,377
+30,095
| +10% | +$161K | 0.28% | 60 |
|
|
2018
Q1 | $1.48M | Buy |
295,282
+268,032
| +984% | +$1.34M | 0.18% | 82 |
|
|
2017
Q4 | $90K | Buy |
+27,250
| New | +$90K | 0.01% | 155 |
|